Dr Reddys Laboratories Ltd has earlier announced about the audit conducted by the USFDA at the formulations manufacturing facilities (FTO 7 & FTO 9) at Duvvada, Visakhapatnam.
Further, in respect of the information, the Company has received the Establishment Inspection Report (EIR) from the USFDA indicating closure of the inspection.
Also, the pharma major stocks is in focus on Monday as Binnopharm Group inks pact to acquire two anti-bacterial brands from the company in the Russia & CIS region.
At around 12:12 PM, Dr Reddys Laboratories was trading at Rs4,354 apiece up by Rs33 or 0.76% against its previous closing of Rs4,321 apiece on the BSE.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
